respiratory conditions

Asthma biologic may reduce oral steroid useA new trial for AstraZeneca’s benralizumab shows promising results for severe asthma patients.
Why there’s an uptick in outcomes-based contractsOperational issues aside, outcomes-based contracts can offer a two-fold benefit for managed care executives.